Low Dose of Sevelamer is Enough to Prevent Coronary Artery Calcification Progression in Prevalent Hemodialysis Patients
Journal Title: Open Access Journal of Urology & Nephrology - Year 2016, Vol 1, Issue 2
Abstract
Objective: Our objective is to study the possible role of low dose sevelamer hydrochloride on the rate of progression of coronary artery calcification among prevalent hemodialysis (HD) patients. Methods: Eighty HD patients were selected to this study. These patients were receiving oral calcium carbonate (CaCO3) as 200mg of elemental calcium with each meal (total of 1500 mg/day). They were randomized into two equal groups. The first group was administered sevelamer hydrochloride as 800 mg with each meal (2400 mg/day) instead of CaCO3 [Group I], while the oral CaCO3 was maintained as 200mg of elemental calcium with each meal in the 2nd group [Group II]. Coronary artery calcification score (CCs) was assessed before stating and at the end of the trial. In addition, serum fibroblast growth factor 23 (FGF23), calcium, phosphorus, lipids and intact parathyroid hormone (PTH) were estimated in these two events. Results: The baseline CCs and serum FGF23 were comparable in the 2 groups (200 ± 98.45 vs. 198 ± 69.68 A and 4669.5 ± 3540.9 vs. 4737 ± 2578.2 pg/ml, P=0.75 and 0.34 for CCs and serum FGF23 in group I vs. group II respectively). On the other hand, CCs and serum FGF23 were significantly lower in group I compared to group II by the end of the trial (203 ± 97.95 vs. 292 ± 100.16 A and 3011.8 ± 1853.7 vs. 7071.5 ± 2650.4 pg/ml, p= 0.012 and <0.001 for CCs and serum FGF23 in group I vs. group II respectively). These significant changes were associated with a highly significant decrease of CaxP product after using sevelamer (53.7 ± 6.5 vs. 65.3 ± 5.55, in group I vs. group II respectively, p<0.001). CCS showed significant correlation with FGF 23 (r=0.634, p<0.001) but failed to show similar correlation with other studied parameters in both groups. Conclusion: Low dose Sevelamer HCL can withhold coronary artery calcification progression in prevalent HD patients, and significantly decreases FGF 23 level. These results may help to overcome the patient intolerance and economic burden of the full dose of sevelamer. Further studies comparing low dose versus full dose of sevelamer are needed in these patients.
Authors and Affiliations
Usama AA Sharaf El Din
Keywords
Related Articles
- EP ID EP487097
- DOI 10.23880/oajun-16000107
- Views 87
- Downloads 0
Laparoscopic Off-Clamp Partial Nephrectomy for Complex RENAL Nephrometry Score Tumours
Partial nephrectomy remains the gold standard approach for patients with localised renal tumours. However it comes with its own peri-operative challenges, especially when dealing with tumours in difficult locations. Seve...
Insignificance of Perirenal Fat Invasion in Small Renal Masses
Objective: To evaluate oncologic outcomes in clinical T1a tumors which remain pathological T1a compared to tumors which were upstaged to pathologic T3a due to perirenal fat invasion. Methods: A retrospective database was...
Paratesticular Masson’s Hemangioma Case Report and Review of the Literature
Masson’s hemangioma or intravascular papillary endothelial hyperplasia is a rare intravascular benign lesion. It may involve a wide variety of organs, most frequently the skin and subcutaneous tissue. Regarding the uroge...
Association between Metabolic Syndrome and UrolithiasisDescriptive Study
The prevalence of kidney stones has been on the rise over the last 2 decades worldwide. Many studies have indicated a possible association between metabolic syndrome and kidney stone disease. Several hypotheses have been...
Isolated Renal Metastasis Mimicking Primary Renal Cell Carcinoma
The majority of isolated renal masses are found to be primary renal cell carcinoma. However, in some rare cases, such a presentation can reveal an underlying metastasis of an occult neoplasm elsewhere. We report here a c...